IRIXHIGH SIGNALOPPORTUNITY10-K

IRIX demonstrated a dramatic operational turnaround with revenue surging 283% while simultaneously cutting net losses in half.

This represents a significant inflection point for IRIX, with the company achieving substantial revenue growth while dramatically improving operational efficiency and cash flow generation. The combination of strong top-line growth, improved margins, and better cash management suggests the business has reached a more sustainable operating model after previous struggles.

Comparing 2026-04-02 vs 2025-03-27View on EDGAR →
FINANCIAL ANALYSIS

IRIX delivered exceptional financial improvement across all key metrics, with revenue exploding from $10.9M to $41.6M while net losses were cut from $8.9M to $4.4M despite the revenue surge. The company strengthened its balance sheet significantly, with cash more than doubling to $6.0M and stockholders' equity increasing 135% to $4.9M, while operating cash flow improved dramatically from -$7.3M to -$2.1M. This comprehensive financial turnaround, combined with reduced R&D spending and minimal share buybacks, signals a company that has successfully scaled its operations and moved toward profitability.

FINANCIAL STATEMENT CHANGES
Capital Expenditure
Cash Flow
+1000%
$13K$143K

Capital expenditure jumped 1000% — major investment cycle underway; assess returns on deployment.

Revenue
P&L
+282.8%
$10.9M$41.6M

Strong top-line growth of 282.8% — accelerating demand or successful expansion into new markets.

Cash & Equivalents
Balance Sheet
+152.5%
$2.4M$6.0M

Cash position surged 152.5% — strong cash generation or capital raise providing significant financial cushion.

Stockholders Equity
Balance Sheet
+134.7%
$2.1M$4.9M

Equity base grew 134.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.

Share Buybacks
Cash Flow
-96.2%
$1.6M$59K

Buyback activity reduced 96.2% — capital being redeployed elsewhere or cash conservation underway.

Operating Cash Flow
Cash Flow
+71%
-$7.3M-$2.1M

Operating cash flow surged 71% — exceptional cash generation, highest quality earnings signal.

Operating Income
P&L
+69%
-$8.3M-$2.6M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Net Income
P&L
+50.2%
-$8.9M-$4.4M

Net income grew 50.2% — bottom-line growth signals improving overall business health.

R&D Expense
P&L
-32.7%
$5.4M$3.7M

R&D spending cut 32.7% — could signal cost discipline or concerning reduction in innovation investment.

Accounts Receivable
Balance Sheet
+27.9%
$6.0M$7.6M

Receivables grew 27.9% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-04-02
PRIOR — 2025-03-27
ADDED
As of March 27, 2026, Registrant ha d 17,307,401 shares of common stock outstanding.
In the fiscal year ended January 3, 2026 ( fiscal year 2025 ) and the fiscal year ended December 28, 2024 ( fiscal year 2024 ), our products were sold in the United States and Germany predominantly through a direct sales force and internationally (aside from Germany, Italy, UK (Glaucoma), India, and other smaller markets) primarily through Topcon Corporation ( Topcon ) and other independent distributors.
Total revenues in fiscal years 2025 and 2024 were $52.7 million and $48.7 million, respectively.
We generated net losses of $4.4 million and $8.9 million in fiscal years 2025 and 2024, respectively.
As a result, we have seen customers extend purchase decision cycles that have impacted and may continue to impact our operations.
+7 more — sign up free →
REMOVED
As of March 21, 2025, Registrant had 16,789,027 shares of common stock outstanding.
In 2024 and 2023, our products were sold in the United States and Germany predominantly through a direct sales force and internationally (aside from Germany, Italy, UK (Glaucoma), India, and other smaller markets) primarily through Topcon Corporation ( Topcon ) and other independent distributors.
Total revenues in 2024 and 2023 were $48.7 million and $51.9 million, respectively.
We generated net losses of $8.9 million and $9.6 million in 2024 and 2023, respectively.
Impact of Macroeconomic Conditions to our Business Current macroeconomic conditions exhibit challenges that can affect capital equipment purchasing demand and timing, including recessionary fears, inflation concerns, changing interest rates, tariffs, trade wars, unexpected changes in taxes or policies, as well as other geopolitical developments and uncertainty, have impacted and may continue to impact business spending and the economy as a whole.
+7 more — sign up free →
MORE OPPORTUNITY SIGNALS
CSAIHIGHCSAI underwent a dramatic financial transformation with revenue growing 271% to ...
2026-03-31
PLMKWHIGHPLMKW has entered into a definitive business combination agreement with Controll...
2026-03-31
LXEOHIGHLXEO achieved significant clinical milestones with positive interim data and reg...
2026-03-30
NPBHIGHNorthpointe Bancshares went public and achieved exceptional financial growth wit...
2026-03-27
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →